Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulse wave velocity and morphology in chronic kidney disease: effect of renin–angiotensin system blockade
2005-001568-29Phase 4Completed
- Sponsor
- Department of Nephrology
- Start
- May 2005
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of enalapril and candesartan in chronic kidney disease (CKD), sponsored by Department of Nephrology. Primary endpoint: Pulse wave velocity difference. Started May 2005; status: completed.
02
Drugs
enalaprilcandesartan
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2005-001568-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001568-29.